The veterinary drugs compounding market is estimated to be valued at US$ 1313.04 Mn or in 2023 and is expected to exhibit a CAGR of 5.5% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market Overview:
Compounded veterinary drugs refer to drugs that are customized for individual animal patients based on a veterinarian's prescription. They are typically prepared in a licensed pharmacy when an FDA-approved veterinary drug may not meet the medical needs of an animal or when an approved form of the drug is not suitable. Common examples include gels, ointments, and flavored medications made to appeal to pets. Compounding allows veterinarians to adjust medication strengths and formulations to meet individual animal's unique needs.
Market Dynamics:
Rising pet population across the globe is expected to aid in growth of the veterinary drugs compounding market. According to an American Pet Products Association report, the number of pet dogs and cats in the U.S. is close to 160 million. Moreover, increasing expenditure on pet healthcare is also expected to support the market growth over the forecast period. The increasing awareness related to animal health have made pet owners more attentive towards their pets disease prevention and treatment, which is expected to propel the demand for compounded drugs. However, higher costs associated with compounding as compared to commercially available drugs may hinder the market growth during the forecast period.
SWOT Analysis
Strength: Veterinary drugs compounding allows for unique formulations tailored to specific patient needs. It gives vets flexibility to customize treatments. Compounded drugs are able to be produced in formulations not readily available from pharmaceutical companies.
Weakness: Compounded drugs are not FDA approved which means their safety and efficacy is not verified. They also have shorter shelf lives than traditional drugs. Compounding pharmacies require specialized equipment and experienced staff which increases costs.
Opportunity: The rising pet population worldwide is driving demand for specialized veterinary care. Customized treatments allow vets to better address rare and complex conditions. Growth in pet insurance and rising pet owner expenditure presents an opportunity to drive sales.
Threats: Off label use of compounded drugs presents safety concerns. Consolidation among major pharmaceutical companies reduces the drug formulations they provide.
Key Takeaways
The Global Veterinary Drugs Compounding Market Size is expected to witness high growth, exhibiting CAGR of 5.5% over the forecast period, due to increasing pet ownership and expenditure. Rising awareness about specialized veterinary care and customizable treatment options is driving the demand for compounded drugs.
Regional analysis
The North America region dominates the Veterinary Drugs Compounding market owing to advanced veterinary infrastructure and growing pet care expenditure in the US and Canada. Rising pet adoption in countries like Brazil and China provide high growth potential to the Asia Pacific region. Meanwhile, Europe is another major revenue generator due to increasing willingness of pet owners to spend more on veterinary treatments.
Key players
Key players operating in the Veterinary Drugs Compounding market are Wedgewood Pharmacy, Pace Pharmacy, Tache Pharmacy, The Pet Apothecary, Pet Script, Golden Gate Veterinary Compounding Pharmacy, CareFirst Specialty Pharmacy, Triangle Compounding Pharmacy, Miller€TMs Pharmacy, and Davis Islands Pharmacy. These players are focusing on expanding their product portfolios and geographic presence to gain a competitive advantage in the market.
Read Our More Blogs : https://www.pressreleasebulletin.com/veterinary-drugs-compounding-market-forecast-outlook-trend-2023/
Sign in to leave a comment.